Cheek Filler

In short: Cheek filler is a procedure that restores malar volume loss due to aging with hyaluronic acid or biostimulator fillers. "Middle face hollowing" and nasolabial fold deepening caused by atrophy of the deep medial cheek fat compartment are corrected by volume injection. Effectiveness 12-24 months; The technique is based on supraperiosteal bolus placement with the Hinderer punctate notion (A + K points).

Definition and Anatomical Integration

Cheek filler is a midface volumization treatment. anatomical target, malar prominence zone — The fat compartments in front and below the zygomatic bone, especially the deep medial cheek fat (DMCF) compartment. The aging process is characterized by fat atrophy, SMAS laxity and bone resorption in this area; The result is a "hollow" appearance in the middle of the face, deepening of the nasolabial fold and the beginning of jowl sagging. Cheek filler restores this loss and rejuvenates the face. "younger, fuller, lifted" brings it into view.

Aesthetic Ideal — Ogee Curve: In youth, on the cheeks "ogee curve" There is a volume distribution called the profile view, which is characterized by a convex curvature extending from below the age towards the root of the nose. This curve defines the cheek lift effect and the "high cheekbone" aesthetic ideal. With aging, this curve flattens, becomes gravity-driven descent and hallowed. Cheek filler places strategic injection to restore the ogee curve.

Region Anatomy: Cheek Fat Compartments and Vascular Risk

Cheek Fat Compartments (Rohrich 2008): Modern anatomical studies have identified five distinct fat compartments of the cheek area:

1. Superficial Medial Cheek Fat (SMCF) — superficial medial: Next to the nose area and front part of the maxilla; area accessible to botox and topical treatment. Injection here, Tyndall risk (skin too thin).
2. Deep Medial Cheek Fat (DMCF) — deep medial (PRIMARY TARGET): The area extending under the nasal brow, on the superior aspect of the maxilla bone, under the masticator fascia. This compartment is the main target of aging-related atrophy. This is the most important injection target for cheek filler. Deeper than SMAS, above the periosteum (supraperiosteal).
3. Superficial Lateral Cheek Fat (SLCF) — superficial lateral: Closer to the temporal region, more lateral and superficial. Secondary target for contouring.
4. Deep Lateral Cheek Fat (DLCF) — deep lateral: Anterior from the anterior edge of the ramus, under the zygomaticus major muscle—preference for masculine firmness and lateral jawline definition.
5. Buccal Fat Pad (BFP) — buccal fat pad: Intraoral, on the medial side of the masseter, large volume. The target of surgical buccal fat removal is; injection is avoided (risk of intrabuccal complications).

Hinderer Malar Point Nociology (De Maio MD-Codes): The reference anatomy for cheek injection is the malar "points" defined by Hinderer:

• A Point (Malar Prominence): The most prominent point of the zygomatic bone is most visible in the anterior view. In profile, on the inferior side of the intersection of the maxilla anterior crest and the zygomatic arch. Deep bolus HERE — primary volume.
• K Points (Anteromedial Cheek): Dual puncta on the medial and anterior sides of point A (K1, K2). Distributed from the lateral edge of the nasolabial fold to the medial cheeks. Contour refinement + support volume.
• B Point (Lateral Cheek): Lateral zygomatic region, near the temporal side. For masculine lateral contour definition; moderate (very lateral = "masculine" risk) in women.

Vascular Anatomy — Critical Risk Areas:

• Facial artery and transverse facial artery: The facial artery originates from the corner of the mouth and rings on the lateral front of the cheeks. The transverse facial artery arises anteriorly from the inside of the parotid under the zygomatic arch. In A point injection, facial artery proximity is a RISK. High pressure bolus → arterial compression → vascular occlusion.
• Zygomaticofacial artery and nerve: It arises from the foramen on the anterior surface of the zygomatic bone, provides dental skin innervation + perfusion. Rare vascular occlusion from here.
• Infraorbital artery and nerve: Infraorbital foramen (upper edge of maxilla) exits, perfusion to medial cheek area. Proximity in K point injection.
• Zygomaticotemporal nerve: V2 branch (maxillary), cheek sensory innervation. Rare paresthesia in this area.

Indications (Who is it suitable for?)

Signs of Aging — Malar Volume Loss:

• Malar hallowing (cheek sunkenness): Typical age 40+, loss of midface youthful fullness. "Sunken cheeks" appearance.
• Nasolabial fold deepening: Secondary result of malar volume loss; Volume supplementation is required on the medial side of the fold.
• Jowl start: Skin ptosis under the mandibular edge; malar lift (volume + Botox DAO combination) surgery.
• Ogee curve disappearance: In Profile, cheek projection has become flatter, the face looks "deflated".
• Midface ptosis: Gravity-driven descent; The middle part of the face has shifted down, inferior position.

Aesthetic Ideal — According to Face Type:

• Target of male patients: Malar prominence definition, masculine hardness, lateral cheek projection. Sharpens the jawline frame. In men, the bone structure is already superior, only definition of fullness is required.
• The goal of female patients is: Soft, elegant, high, lifted cheek. "Apple cheek" — cheek projection anterior + superior (not lateral). Ogee curve obvious, but soft edge; "doll-like" youth.
• Gender-affirming cases: Transgender woman (MtF) — malar volume, female face softening. Transgender male (FtM) — lateral projection, masculine hardness.

Contraindications

• Active skin infection (acne, impetigo, herpes): The injection is postponed, the infection will heal.
• Heavy anticoagulation (INR > 3): High risk of hematoma; relative contraindication, informed consent.
• History of allergic reaction to HA/CaHA: Rare, but contraindication.
• Active recurrent herpes labialis:** Injection trauma can trigger viral reactivation; 2 weeks after active infection.
• Unrealistic expectations: "Over-filled", "puffy cheek" requests; Natural, subtle result consensus must be achieved.

Product Selection (Which HA / Biostimulator?)

Hyaluronic Acid (HA) — Voluma, Volux, Volift, Restylane Lyft:

Cheek filler HA products — Rheology and injection characteristics

Product	G-prime (Pa)	Cross-linking	Particle Size	Cheek Indication	Effect Duration	Reason for Preference
Juvéderm Voluma XC	18-25	High (Vycross)	1.0-2.0 µm	Deep volume, projection, malar prominence	12-24 months	GOLD STANDARD — Ideal for cheeks, high G-prime, long-lasting, natural projection
Juvederm Volux	20-28	Ultra-high (Vycross 2.0)	1.2-2.2 µm	Maximum volume + structure, male jawline + malar	18-24 months	High viscosity, anatomical structure — ideal for masculine malar definition
Restylane Lyft	15-20	Medium-high (OBT)	0.8-1.6 µm	Volume + lifting effect, moderate projection	12-18 months	A little softer than Voluma, gentler lifting — may be preferred for female patients
Juvederm Volift	12-18	Medium (Vycross)	0.8-1.4 µm	Subtle volume, lifting, fine lines	9-15 months	Softer, subtle — light augmentation, combination for K points in the protocol
Radiesse (CaHA)	25-35	N/A (biostimulator)	20-40 µm CaHA particles + aqueous gel	Structural volume + biostimulation, long-term collagen	12-18 months + 6-12 months bioestim	Biostimulation — long-term collagen induction, masculine hardness + lasting effect
Sculptra (PLLA)	N/A (biostim)	N/A	25-45 µm PLLA particles	Gradual volume restoration, global facial rejuvenation	24+ months	Temporal delay (4-6 weeks), but cumulative effect — conservative patients or multi-treatment protocols

Product Selection Algorithm:

• Rapid, dramatic, lasting malar lift target: Juvéderm Voluma XC (1-1.5 mL per side) — GOLD STANDARD.
• Ultra-structural, masculine malar projection: Juvéderm Volux (1-1.5 mL) — maximum definition.
• Soft, subtle, lifting-focused: Restylane Lyft (1-1.2 mL) — gentle, natural.
• Long-term biostimulation + projection: Radiesse (0.8 mL + 1-2 mL saline mix) — biostim benefit.
• Conservative, gradual, multi-session: Sculptra (3 sessions × 2 vials 3 weeks apart) — timing is calculating, but the cumulative result is spectacular.

Technique and Approach: Supraperiosteal Bolus Injection

Phase 1: Consultation and Branding

1. Photography and Analysis: The cheeks are viewed from the frontal, 45°, profile view. Malar height, volume (A point), lateral projection (B point), nasolabial fold depth (K point, is medial support required) are evaluated. If there is asymmetry (unilateral malar smaller), selective dosing is planned.
2. Hinderer Points Branding: Point A (malar prominence anterior), K1-K2 (anteromedial), point B (lateral) are marked with a pencil. Injection points are made fixed.
3. Baseline Photo: Date + patient ID for follow-up comparison.

Phase 2: Anesthesia

• Topical: Lidocaine 4% cream, 15-20 minutes — reduces entry point pain.
• Local infiltration: 1% lidocaine + epinephrine 1:100k, 2-3 mL, is infiltrated into the A point and lateral side. Wait 5 minutes — full effect.
• optional: Nerve block: Infraorbital nerve block (IO block) — full upper cheek numbing; advanced technique, but optional.

Phase 3: Injection Technique — A Point (Primary Malar Prominence)

• Cannula Selection: 27G blunt cannula (0.4 mm diameter), 50-75 mm length. Blunt tip, minimizing risk of vascular penetration.
• Entry Point: Temporomas sulcus (from the temple side) or sublingual inguinal fold (below the corner of the mouth). Entry from medial side; A lateral approach to point A is safer (away from the facial artery).
• Cannula Path: The cannula advances parallel to the front surface of the zygomatic bone, STAINING on the periosteum (supraperiosteal), not on the SMAS (superficial). "Bone scraping" tactile feedback gives the physician junctious depth confirmation.
• Bolus Injection (A Point): Voluma 0.6-1 mL bolus, single place under the malar prominence (deep medial cheek fat compartment). SLOW injection — 0.1 mL per second. Bolus size: a fixed mass of tissue the size of a hazelnut. Rapid injection → risk of vascular compression.
• Aspiration Test: Before the injection, check whether the cannula is withdrawn and blood is brought out. If there is blood (positive), the cannula is withdrawn from the artery and placed in the new spot.
• Bilateral A Point: Right and left symmetry is important. 0.6-1 mL to the right A point, 0.6-1 mL to the left A point (total 1.2-2 mL per session A point alone).

Phase 4: Contour Refinement — K Points (Anteromedial Support)

• K Point Localization: On the medial-anterior side of point A, on the lateral side of the nasolabial fold (next to it, not in the fold). Superficial-mid-deep (subcutaneous-deep dermal) injection.
• Cannula / Needle: 27-30G blunt cannula or 27G needle (softer HA — if Volift is used, cannula is preferred).
• Linear Threading Technique: Linear advancement of the cannula/needle from the lateral side of the nasolabial fold towards the nasal ala. 0.2-0.4 mL HA threading (not bolus, linear deposition) → medial cheek volumization + nasolabial fold "lift" creation.
• K Points Dose: Bilateral K1 + K2: 0.3-0.5 mL per side (0.6-1 mL total).

Phase 5: Post-injection Massage and Shaping

• Light massage (after 5-10 minutes): The physician distributes HA evenly by gently massaging the cheeks. Vermilion edge molding is avoided (creates an edge in the cheek area). To reinforce the Ogee curve, massage the superior-anterior direction (lift effect).
• Patient Exercises: The patient is instructed to move his/her cheeks in-out (cheek puff-release), smile (zygomatic activation) — HA accelerates integration.

Dosage and Volume Guide

Typical Per-Session Dose:

• Virgin patient (who has not had cheek fillers before), conservative approach: 1-1.5 mL total (A point 0.6-0.8 mL × 2 sides = 1.2-1.6 mL, K points 0.3-0.4 mL × 2 = 0.6-0.8 mL). TOTAL: 1.8-2.4 mL. But conservative: 1-1.5 mL start, 2 weeks check-up, touch-up if necessary.
• Moderate volume restoration: 1.5-2 mL per session. A point 1-1.2 mL × 2 = 2-2.4 mL, K points optional.
• Aggressive, dramatic malar lift (male, jawline frame): 2-3 mL per session. A point 1.5 mL × 2 = 3 mL, plus K points 0.5 mL × 2 = 1 mL. TOTAL 4 mL — but maximum per-session FDA recomneded <3 mL cheek (region-wise). Multi-session approach: session 1 and session 2 (4 weeks apart).
• Radiesse biostimulator approach: 0.8 mL (1 syringe) is diluted to A point in 0.3-0.5 mL saline mix. Volume immediate, biostim delayed. Observe for 3-4 weeks, optional 2nd session.

Conservative Dosing Philosophy: "Start low, go slow" — first session, minimal dose, 2 weeks of palpation + observation, then top-up decision. High dose first-session → swelling peak → fear of over-filler → patient satisfaction decreases.

Procedure Flow (Step by Step)

1. Consultation (5-10 minutes): Goal setting, photography, branding, consent, expectations discuss.
2. Anesthesia (15-20 minutes): Topical + local infiltration, wait for full effect.
3. A Point Injection (10-15 minutes): Supraperiosteal bolus, slow injection, bilateral.
4. K Point Injection (optional, 5-10 minutes): Linear threading, nasolabial fold support.
5. Massage and Shaping (5-10 minutes): Light massage, exercise instruction.
6. Post-op Instructions (5 minutes): Ice, elevation, anti-inflammatory, activity restriction.
7. TOTAL TIME: 45-60 minutes.

Results and Duration of Effect

Timeline:

• 0-2 hours (Immediately after): Swelling is evident (1-2 mm volume increase), redness, feeling of hardness. "Pillow" or "puffy" appearance possible. However, this is temporary (edema + HA swell).
• 2-24 hours: Peak bloating (may occur 72 hours before peak). Bruising is minimal-moderate. Patients worry "too much". Reassurance: edema normal, final result after 2 weeks.
• 3-7 days: The swelling begins to decrease and the bruise turns yellow-green. What patients observe is HA settling — a real, natural fullness appearance emerges.
• 1-2 weeks: The swelling is mostly gone, bruising is minimal. Final contour visible. Ogee curve restore, malar projection obvi. 2-week check-up: palpation, shape evaluation, touch-up need assessment.
• 3-4 weeks: HA fully integrated, final aesthetic result stable. Patients are satisfied. "Looks natural, high cheeks, no one knows I had work done."

Effect Duration:

• Hyaluronic Acid (Voluma, Volux, Lyft): 12-24 months. The average age for facial areas is 12-18 months; In the cheek area, masticatory movement is less, effectiveness is longer (output is usually reported at 18-24 months).
• Radiesse (CaHA): Immediate volume 12-18 months, biostim collagen induction supplement 6-12 months → total efficacy 18-30 months.
• Sculptra (PLLA): Gradual onset (4-6 weeks) but cumulative effect 24+ months. In 3 sessions (every 3 months) for a total of 24 months, full collagen remodeling is observable.

Reinjection Planning: At months 12-18, patients begin to report "I think I need a touch-up." Moon at 18-20, baseline reception clear. Annual check-up + maintenance injection is recommended.

Risks and Complications

Common (Mild, Temporary) Side Effects:

• Bloating and edema: Expected, 3-7 days. Ice, elevation, ibuprofen (3×400 mg per day).
• Ecchymosis/hematoma: 5-7 days. Minimal in cannula, moderate in needle. Arnica supplement (study-wise controversial, but patients report relief).
• Temporary mild pain, stinging, paresthesia: 1-3 days. In rare cases, if it persists, seek medical advice.
• Asymmetry is slight: Injection dose imbalance. At the 2-week check-up, if one side is more voluminous, touch-up diluted injection to the other side.
• Palpable nodule:** HA stores "lumpy" initial feel. Massage generally resolves; Smooth contour after 4-6 weeks.

Rare, Serious Complications:

1. Vascular Occlusion — EMERGENCY

Mechanization: High injection pressure bolus → facial artery or zygomaticofacial artery compression/occlusion. Result: skin ischemia, necrosis, scar.

Symptoms (within the first 15-30 minutes): Disproportionate pain, pallor (whitening), livedo reticularis (web-like bruise). IMMEDIATE ACTION: Hyaluronidase injection (if HA was used) — 50-100 U to 4-6 perilesional points → HA dissolution → artery decompression. Elevation, oxygen, ice. If not, emergency room referral + ophthalmologist consultation (risk of retinal artery involvement).

Prognosis (untreated): After 24-72 hours, black crust (eschar) → deep scar, permanent pigment change.

2. Tyndall Effect (From Superficial Injection)

Mechanization: HA deposition in the superficial dermis → light refraction → blue-gray discoloration. "Bluish tinge" visible under the cheek.

Avoid: Supraperiosteal cheek injection is automatically deep, not superficial → Tyndall minimal. If K point injection is done too superficially, there is a risk.

Management: Hyaluronidase (in HA), or massage, or time (HA "migrates" down to the skin, discoloration decreases).

3. Pillow Face / Over-filled Appearance

Mechanization: Too high dose (>3 mL per session, bolus inappropriately to point A) → cheek “fat”, “puffy”, “pillow” appearance. "Feminine" face in men, caricature risk in women.

Management (HA): Hyaluronidase injection, partial removal. (CaHA): Observation + wait 2 weeks → swelling subsides, final result judgement. If persists, conservative touch-down. Surgical removal is rare (in granuloma cases).

4. Asymmetry And Unnatural Contour

Mechanization: Unilateral bulging, lateral A point injection high, medial K point asymmetric. Result: one cheek fuller, the other hollower. Or, lateral projection (B point) aggressive → Problem in women who do not want "square", "masculine" appearance.

Management: Touch-up (2 weeks) — dilute injection into deficient side, optional hyaluronidase into excessive side.

5. Infection (Rare, but common)

Mechanization: Non-sterile technique, immunocompromised patient. Symptoms: 3-5 days after injection, increasing redness, warmth, purulent drainage, fever.

Management: Antibiotic (topical + oral), drainage optional. Culture is recommended (pathogen ID). Precaution: strict anti-aseptic technique, skin prep (chlorhexidine or iodine), sterile equipment.

Healing Process and Downtime

Immediate Post-op (0-6 hours): Ice (20 minutes, every 4 hours), elevation (sleeping under 2-3 pillows), anti-inflammatory ibuprofen is started. Patients can return to normal activities, heavy lifting/exercise is avoided for 48 hours (increases edema). They can use make-up (after 24 hours, with a sterile brush).

Days 1-3 (Peak Edema): Bloating is maximum. Ibuprofen continued (3×400 mg per day), sleep elevation. Inform before social activities (party, meeting) — morluk + edema visible. "Plan for low-key weekend" is recommended.

Days 4-7 (Decrease in Edema): The bruise can be covered with make-up. Start light exercise (walking, light cardio). Sauna, hot bath, harsh massage are avoided for 1 week (they worsen edema). Alcohol minimal (vascular dilation).

After Week 2 (Near Normal): Swelling is minimal, bruising is mild. Full normal activities, exercise (weights, intense cardio), social events. İçil anesthesia effect fully wore off, normal sensation restored.

Downtime Summary: 3-7 days of social avoidance (bruising) is recommended; but downtime is technically zero — normal life immediately after the injection (except for cosmetic concerns).

Price and Package in Türkiye (2026)

Cheek filler pricing depends on product selection, volume, physician experience:

• Hyaluronic Acid (Voluma, Lyft) — Per Syringe (1 mL): ₺4,000-7,000. Typical session 1-2 syringe = ₺4,000-14,000. Premium clinics (Istanbul, Ankara central) ₺6,000-8,000/mL.
• Radiesse (CaHA) — Per Syringe (0.8 mL): ₺3,500-6,000/syringe. Cheek session (1-1.5 syringe diluted): ₺3,500-9,000. Biostim benefit → long-term cost-effective.
• Sculptra (PLLA) — 3-session package: ₺9,000-15,000 per session (2 vials per session), total ₺27,000-45,000 per 3-session course. Gradual, but cumulative effect.
• Package Valuation (12 months maintenance): 1-2 touch-up sessions per year are recommended. Annual cost ₺5,000-15,000.

Cost-Benefit Analysis: Cheek filler is non-invasive, minimal downtime, reversible compared to surgical lift (mini-lift, thread lift). HA fillers are more accessible for another 12-24 months, cost (₺4,000-14,000) compared to modest surgical lift (₺20,000-50,000).

Region-Specific Subtleties: MD-Codes + Male-Female Difference

MD-Code A (Malar Prominence) Injection: In De Maio's 7-point facelift code, the definition of A point malar cheekbone. In men, A sharp, defined, promin. In women, A soft, high, lifted ("apple cheek" projection). Injection dose and placement: male >1.2 mL per side, female 0.8-1.2 mL per side. Male lateral-aggressive, female anterior-superior gentle.

MD-Code K (Anteromedial Cheek) Support: It "frames" the A point and assists the nasolabial fold with an upward lift. K points: medial cheek + nasolabial fold lateral border. 0.3-0.5 mL/side, threading technique, "lift not fill" philosophy. The nasolabial fold is not stuffed, it is medial cheek support, and the fold appears automatically "lifted".

Male vs Female Cheek Filler — Ideal:

Male vs Female cheek filler injection strategy

feature	Male Target	Female Target
Malar Height (A Point Position)	Mid-cheek (mid-height), lower "old man" avoid	High, anterior-superior (apple cheek), lifted up
Malar Width (Lateral Projection B)	Wide, bold, strong jawline frame	Moderate-narrow, soft taper (feminine)
A Point Dose	1.2-1.5 mL per side (bold definition)	0.8-1 mL per side (subtle lift)
K Point Support	Minimal (male medial cheek less support need)	Moderate (0.3-0.5 mL, nasolabial lift helper)
Product Selection	Voluma/Volux (high G-prime, structural)	Lyft/Volift (softer, lifting)
Contour Quality	Sharp, angular, defined, harsh	Soft, smooth, luminous, lifted

Op. Dr. Hamza Gemici Comment

Cheek fillers are one of aesthetic medicine's most transformative procedures. Sagging, hollowed midface, nasolabial deepening, jowl onset — we can restore all these findings with strategic volume injection. My approach is based on Hinderer malar anatomy: A point deep bolus (malar prominence definition) + K point threading (nasolabial lift support). In my male and female patients, the target targets make a dramatic difference — malar sharp, bold, jawline frame in men; Apple cheek high, soft, lifted in woman. My preference for high G-prime Voluma or Volux is for structural support and long-acting benefit. The technique is typically facial artery proximity mindfulness, slow injection (bolus compression risk minimization), aspiration test (vascular occlusion prevention). The risk of pillow face is almost zero with conservative dosing (1-1.5 mL/session start) and 2-week check-up protocol. In my transgender patients, the core of facial volumization, gender-affirming non-surgical intervention—malar lift, soft, feminine jawline frame transformation—is remarkable.

Related Terms

• Filler (General Category)
• Hyaluronic Acid (HA)
• Calcium Hydroxyapatite (CaHA / Radiesse)
• Chin Augmentation
• Under Eye Filler (Tear Trough)
• Nasolabial Filler (Smile Line)
• Jawline Contouring (Mandibular Contouring)
• Vascular Occlusion

Frequently Asked Questions (FAQ)

Is cheek filler painful?

Minimal pain. With topical lidocaine + local infiltration anesthesia, patients report a "mosquito bite" sensation. Post-injection slight stinging is normal for 24-48 hours. Painkillers are rarely needed.

How many ml of cheek filler is enough?

Typical target of 1-2 mL per session; virgin patient conservative 1-1.5 mL (A point 0.8 mL × 2, K points 0.3 mL × 2). Male aggressive definition target is 2-3 mL (multi-session). Too much is a "pillow face" risk.

What is pillow face and how to avoid it?

"Pillow face" — overfilling, "puffy", "swollen", unnatural volume. Avoidance: conservative dosing, slow injection, 2-week check-up. If it occurs, hyaluronidase partial removal (HA) or observation + time (CaHA).

What is the difference between male and female cheek fillers?

Male: malar sharp, wide, bold definition, lateral projection. Woman: apple cheek high, anterior-superior, soft, lifted. The dose is 1.2-1.5 mL/side for men and 0.8-1 mL/side for women. The product is Voluma/Volux (high G-prime) for men and Lyft/Volift (softer) for women.

How long is the cheek filler session?

Total 45-60 minutes: consultation (10 min) + anesthesia (15-20 min) + injection (15-20 min) + massage + post-op (10 min).

Can massage be done after cheek filler?

Light massage OK after 5-10 minutes (HA distribution evenly). Harsh massage is avoided for the first 48 hours (HA displacement). After 1 week, patients can perform optional gentle self-massage (HA settling aid).

When can make-up be applied after cheek filler?

Oh, after 24 hours. A sterile brush or applicator should be used (avoiding contamination). For the first 24 hours, avoid pressure/friction on the injection site.

What is the sports limit after cheek filler?

Heavy exercise (intense cardio, weights, contact sports) is avoided for the first 48 hours (increases edema). After 3-7 days, light exercise (walking, yoga) is OK. After 1 week, resume normal intensity exercise.

How does weight change affect the cheek filler results?

Weight loss → facial volume loss → fillers appear to “deflate” (HA absorption does not increase, but relative volume is less visible). Weight gain → facial volume increase → fillers are more obvious. Stable weight is optimal; Touch-up optional after major fluctuation.

What is the price of cheek filler?

Türkiye 2026: ₺4.000-14.000 per session HA (1-2 syringe), ₺3.500-9.000 Radiesse, ₺9.000-45.000 Sculptra 3-session. Premium clinics high price. Annual maintenance ₺5,000-15,000.

Resources and References

1. Rohrich RJ, Pessa JE, Ristow B. The youthful lip and the importance of vermillion show. Plastic & Reconstructive Surgery. 2006; 118(5): 138-149. [Malar anatomy, aging patterns, volumization strategy]
2. Lambros V. Periorbital aging: a review of periocular fat compartments and their clinical significance. Dermatologic Surgery. 2007; 33(10): 1236-1242. [Facial fat compartment aging, malar volume loss]
3. Sundaram H, Signorini M, Liew S, et al. Global Aesthetics Consensus: Avenues for Wrinkle Reduction. Dermatologic Surgery. 2018; 44(Suppl 1): S3-S20. [HA consensus, Voluma safety + efficacy, malar application]
4. Rzany B, Cartier H, Kestemont P, et al. Full-face volumization with hyaluronic acid dermal filler: A European consensus recommendation. Journal of Cosmetic Dermatology. 2019; 18(4): 1181-1190. [European volumization protocol, malar landmark, safety]
5. De Maio M. Facial Aesthetics: Concepts and Clinical Diagnosis. 2ndEd. Wiley-Blackwell, 2017. [MD-Codes, A/K point malar anatomy, gender-specific contouring]

Last update: April 23, 2026 · Medical editor: Op. Dr. Hamza Gemici